-transparent.png){kind=logo}
The mechanism of natriuresis following administration of atrial extract is not fully understood. This study related the changes in urinary excretion of electrolytes induced by atrial or ventricular extract to those in urinary excretion of prostaglandin E2 (PGE2) in rats. Both atria were removed from Wistar rats and homogenized in a 1 N acetic acid solution. After centrifugation, the supernatant was lyophilized and then resolved in a 0.1 N acetic acid solution. The apical portions of heart ventricles were similarly prepared, and served as controls. One hundred microliter of the solution containing the extract of 10 mg of tissue were injected intravenously into assay rats, the carotid artery and the urinary bladder of which were cannulated to measure blood pressure and urinary output, respectively. Urinary PGE2 was determined by radioimmunoassay. The atrial extract rapidly lowered blood pressure without changing heart rate. This hypotensive effect was maintained for at least 30 minutes. When the urinary samples obtained before and 10 minutes after the injection of the atrial extract were compared, urinary volume and excretion of sodium (UNaV) and potassium (UKV) were increased by 8, 24 and 3-fold, respectively. Urinary excretion of PGE2 (UPGEV) was increased from 5.3 +/- 0.9 (SE) to 16.3 +/- 2.9 ng/kg/10 min (p less than 0.001). There was a significant positive correlation between UNaV and UPGEV in all the samples (r = 0.72, p less than 0.001), and between the changes in UNaV and those in UPGEV after administration of the atrial extract (r = 0.62, p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
December 1978,
Clinical science and molecular medicine. Supplement,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
February 1978,
Prostaglandins,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
January 1988,
Prostaglandins, leukotrienes, and essential fatty acids,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
July 1983,
Clinical science (London, England : 1979),
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
July 2002,
Journal of human hypertension,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
September 1981,
The Journal of clinical endocrinology and metabolism,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
May 1983,
Naunyn-Schmiedeberg's archives of pharmacology,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
June 1987,
Journal of clinical hypertension,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
August 1979,
Naunyn-Schmiedeberg's archives of pharmacology,
M Ishii, and
T Sugimoto, and
T Kobayashi, and
Y Uehara, and
Y Hirata, and
H Matsuoka, and
T Ikeda, and
T Sugimoto
September 1982,
Nutrition reviews,
